Sarah Earley

434 total citations
9 papers, 380 citations indexed

About

Sarah Earley is a scholar working on Molecular Biology, Oncology and Immunology and Allergy. According to data from OpenAlex, Sarah Earley has authored 9 papers receiving a total of 380 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Immunology and Allergy. Recurrent topics in Sarah Earley's work include PARP inhibition in cancer therapy (3 papers), Click Chemistry and Applications (2 papers) and Angiogenesis and VEGF in Cancer (2 papers). Sarah Earley is often cited by papers focused on PARP inhibition in cancer therapy (3 papers), Click Chemistry and Applications (2 papers) and Angiogenesis and VEGF in Cancer (2 papers). Sarah Earley collaborates with scholars based in United States, Australia and Vietnam. Sarah Earley's co-authors include George E. Plopper, Ralph Weissleder, Thomas Reiner, Edmund J. Keliher, Brett Marinelli, Yunqing Chen, Bradley Ferguson, Haibo Liu, Xicheng Zhang and Cesar M. Castro and has published in prestigious journals such as Angewandte Chemie International Edition, Nature Communications and Cancer Research.

In The Last Decade

Sarah Earley

9 papers receiving 374 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sarah Earley United States 9 182 96 90 79 79 9 380
Daniel A. Pearson United States 13 237 1.3× 84 0.9× 163 1.8× 45 0.6× 143 1.8× 24 629
Raghavendra Vasudeva Murthy India 12 215 1.2× 34 0.4× 52 0.6× 54 0.7× 67 0.8× 22 398
Xinyong Ma China 8 173 1.0× 27 0.3× 52 0.6× 51 0.6× 22 0.3× 10 332
Chia‐Hua Chen Taiwan 14 260 1.4× 81 0.8× 122 1.4× 29 0.4× 82 1.0× 28 590
Shabbir Ahmed Khan United States 13 215 1.2× 44 0.5× 107 1.2× 16 0.2× 35 0.4× 35 411
Yingying Jing China 13 241 1.3× 29 0.3× 36 0.4× 122 1.5× 54 0.7× 30 553
Giuseppe A. Papalia United States 12 494 2.7× 23 0.2× 52 0.6× 115 1.5× 88 1.1× 14 721
Rodney A. Jue United States 10 330 1.8× 56 0.6× 38 0.4× 60 0.8× 64 0.8× 14 601
Tatsuto Kiwada Japan 15 224 1.2× 16 0.2× 80 0.9× 75 0.9× 63 0.8× 22 436

Countries citing papers authored by Sarah Earley

Since Specialization
Citations

This map shows the geographic impact of Sarah Earley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Earley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Earley more than expected).

Fields of papers citing papers by Sarah Earley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Earley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Earley. The network helps show where Sarah Earley may publish in the future.

Co-authorship network of co-authors of Sarah Earley

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Earley. A scholar is included among the top collaborators of Sarah Earley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Earley. Sarah Earley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Periasamy, Sivakumar, K. A. Porter, Maninjay Atianand, et al.. (2017). Pyrin-only protein 2 limits inflammation but improves protection against bacteria. Nature Communications. 8(1). 15564–15564. 19 indexed citations
2.
Keliher, Edmund J., Thomas Reiner, Sarah Earley, et al.. (2013). Targeting Cathepsin E in Pancreatic Cancer by a Small Molecule Allows In Vivo Detection. Neoplasia. 15(7). 684–IN3. 39 indexed citations
3.
Earley, Sarah, Claudio Vinegoni, Joshua Dunham, et al.. (2012). In Vivo Imaging of Drug-Induced Mitochondrial Outer Membrane Permeabilization at Single-Cell Resolution. Cancer Research. 72(12). 2949–2956. 14 indexed citations
4.
Reiner, Thomas, Edmund J. Keliher, Sarah Earley, Brett Marinelli, & Ralph Weissleder. (2011). Synthesis and In Vivo Imaging of a 18F‐Labeled PARP1 Inhibitor Using a Chemically Orthogonal Scavenger‐Assisted High‐Performance Method. Angewandte Chemie International Edition. 50(8). 1922–1925. 91 indexed citations
5.
Reiner, Thomas, Edmund J. Keliher, Sarah Earley, Brett Marinelli, & Ralph Weissleder. (2011). Synthese und In‐vivo‐Bildgebung eines 18F‐markierten PARP1‐ Inhibitors mithilfe eines chemisch orthogonalen, Abfangreagens‐ gestützten Hochdurchsatzverfahrens. Angewandte Chemie. 123(8). 1963–1966. 11 indexed citations
6.
Reiner, Thomas, et al.. (2010). Bioorthogonal Small‐Molecule Ligands for PARP1 Imaging in Living Cells. ChemBioChem. 11(17). 2374–2377. 54 indexed citations
7.
Earley, Sarah & George E. Plopper. (2007). Phosphorylation of focal adhesion kinase promotes extravasation of breast cancer cells. Biochemical and Biophysical Research Communications. 366(2). 476–482. 22 indexed citations
8.
Liu, Haibo, George E. Plopper, Sarah Earley, et al.. (2006). Sensing minute changes in biological cell monolayers with THz differential time-domain spectroscopy. Biosensors and Bioelectronics. 22(6). 1075–1080. 92 indexed citations
9.
Earley, Sarah & George E. Plopper. (2006). Disruption of focal adhesion kinase slows transendothelial migration of AU-565 breast cancer cells. Biochemical and Biophysical Research Communications. 350(2). 405–412. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026